130 related articles for article (PubMed ID: 36715344)
1. Raman spectroscopy system for real-time diagnosis of clinically significant prostate cancer tissue.
van Breugel SJ; Low I; Christie ML; Pokorny MR; Nagarajan R; Holtkamp HU; Srinivasa K; Amirapu S; Nieuwoudt MK; Simpson MC; Zargar-Shoshtari K; Aguergaray C
J Biophotonics; 2023 May; 16(5):e202200334. PubMed ID: 36715344
[TBL] [Abstract][Full Text] [Related]
2. Image-guided Raman spectroscopy navigation system to improve transperineal prostate cancer detection. Part 1: Raman spectroscopy fiber-optics system and in situ tissue characterization.
Picot F; Shams R; Dallaire F; Sheehy G; Trang T; Grajales D; Birlea M; Trudel D; Ménard C; Kadoury S; Leblond F
J Biomed Opt; 2022 Sep; 27(9):. PubMed ID: 36045491
[TBL] [Abstract][Full Text] [Related]
3. Mesoscopic characterization of prostate cancer using Raman spectroscopy: potential for diagnostics and therapeutics.
Aubertin K; Trinh VQ; Jermyn M; Baksic P; Grosset AA; Desroches J; St-Arnaud K; Birlea M; Vladoiu MC; Latour M; Albadine R; Saad F; Leblond F; Trudel D
BJU Int; 2018 Aug; 122(2):326-336. PubMed ID: 29542855
[TBL] [Abstract][Full Text] [Related]
4. Image-guided Raman spectroscopy navigation system to improve transperineal prostate cancer detection. Part 2: in-vivo tumor-targeting using a classification model combining spectral and MRI-radiomics features.
Grajales Lopera DO; Picot F; Shams R; Dallaire F; Sheehy G; Alley S; Barkati M; Delouya G; Carrier JF; Birlea M; Trudel D; Leblond F; Ménard C; Kadoury S
J Biomed Opt; 2022 Sep; 27(9):. PubMed ID: 36085571
[TBL] [Abstract][Full Text] [Related]
5. Pre-clinical evaluation of an image-guided in-situ Raman spectroscopy navigation system for targeted prostate cancer interventions.
Shams R; Picot F; Grajales D; Sheehy G; Dallaire F; Birlea M; Saad F; Trudel D; Menard C; Leblond F; Kadoury S
Int J Comput Assist Radiol Surg; 2020 May; 15(5):867-876. PubMed ID: 32227280
[TBL] [Abstract][Full Text] [Related]
6. Stimulated Raman histology, a novel method to allow for rapid pathologic examination of unprocessed, fresh prostate biopsies.
Mannas MP; Jones D; Deng FM; Hoskoppal D; Melamed J; Orringer DA; Taneja SS
Prostate; 2023 Aug; 83(11):1060-1067. PubMed ID: 37154588
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
8. Diffuse reflectance spectroscopy can differentiate high grade and low grade prostatic carcinoma.
Werahera PN; Jasion EA; Crawford ED; Lucia MS; van Bokhoven A; Sullivan HT; Kim FJ; Maroni PD; Port JD; Daily JW; La Rosa FG
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():5148-5151. PubMed ID: 28325017
[TBL] [Abstract][Full Text] [Related]
9. Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care.
Ukimura O; Coleman JA; de la Taille A; Emberton M; Epstein JI; Freedland SJ; Giannarini G; Kibel AS; Montironi R; Ploussard G; Roobol MJ; Scattoni V; Jones JS
Eur Urol; 2013 Feb; 63(2):214-30. PubMed ID: 23021971
[TBL] [Abstract][Full Text] [Related]
10. Systematic diagnosis of prostate cancer using an optical biopsy needle adjunct with fluorescence spectroscopy.
Werahera PN; Jasion EA; Crawford ED; La Rosa FG; Lucia MS; van Bokhoven A; Sullivan HT; Port JD; Maroni PD; Daily JW
Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():2165-8. PubMed ID: 25570414
[TBL] [Abstract][Full Text] [Related]
11. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
12. Deep neural maps for unsupervised visualization of high-grade cancer in prostate biopsies.
Sedghi A; Pesteie M; Javadi G; Azizi S; Yan P; Kwak JT; Xu S; Turkbey B; Choyke P; Pinto P; Wood B; Rohling R; Abolmaesumi P; Mousavi P
Int J Comput Assist Radiol Surg; 2019 Jun; 14(6):1009-1016. PubMed ID: 30905010
[TBL] [Abstract][Full Text] [Related]
13. Human feasibility study of fluorescence spectroscopy guided optical biopsy needle for prostate cancer diagnosis.
Werahera PN; Jasion EA; Liu Y; Daily JW; Arangua P; Jones C; Nash SR; Morrell M; Crawford ED
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():7358-61. PubMed ID: 26737991
[TBL] [Abstract][Full Text] [Related]
14. Augmenting MRI-transrectal ultrasound-guided prostate biopsy with temporal ultrasound data: a clinical feasibility study.
Imani F; Zhuang B; Tahmasebi A; Kwak JT; Xu S; Agarwal H; Bharat S; Uniyal N; Turkbey IB; Choyke P; Pinto P; Wood B; Moradi M; Mousavi P; Abolmaesumi P
Int J Comput Assist Radiol Surg; 2015 Jun; 10(6):727-35. PubMed ID: 25843948
[TBL] [Abstract][Full Text] [Related]
15. Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.
Druskin SC; Tosoian JJ; Young A; Collica S; Srivastava A; Ghabili K; Macura KJ; Carter HB; Partin AW; Sokoll LJ; Ross AE; Pavlovich CP
BJU Int; 2018 Apr; 121(4):619-626. PubMed ID: 29232037
[TBL] [Abstract][Full Text] [Related]
16. Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer.
Qian H; Shao X; Zhu Y; Fan L; Zhang H; Dong B; Wang Y; Xu F; Zhen W; Kang X; Chen N; Liu S; Pan J; Xue W
Urol Oncol; 2020 Jun; 38(6):601.e1-601.e9. PubMed ID: 32241690
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging-guided prostate biopsy: present and future.
Kim CK
Korean J Radiol; 2015; 16(1):90-8. PubMed ID: 25598677
[TBL] [Abstract][Full Text] [Related]
18. Establishment and prospective validation of an SUV
Jiao J; Kang F; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W; Yang X; Yuan J; Shi Y; Wang J; Qin W
Theranostics; 2021; 11(17):8396-8411. PubMed ID: 34373749
[No Abstract] [Full Text] [Related]
19. Evaluation of Prostate HistoScanning as a Method for Targeted Biopsy in Routine Practice.
Glybochko PV; Alyaev YG; Amosov AV; Krupinov GE; Nir D; Winkler M; Ganzha TM
Eur Urol Focus; 2019 Mar; 5(2):179-185. PubMed ID: 28753891
[TBL] [Abstract][Full Text] [Related]
20. Emerging MR methods for improved diagnosis of prostate cancer by multiparametric MRI.
Dwivedi DK; Jagannathan NR
MAGMA; 2022 Aug; 35(4):587-608. PubMed ID: 35867236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
